India is working towards augmenting health infrastructure and have initiated multiple schemes to strengthen health systems and improve health service delivery
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
AKS-452 is currently undergoing Phase II/III clinical testing in India as a primary vaccine; submission for Emergency Use Authorization (EUA) expected by Q3 2022
University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines
The business is a recognized leader in managing Covid-19 and mRNA research programs
Sputnik Light can become a major booster for those vaccinated with inactivated Chinese Covid-19 vaccines globally after China has officially recommended mix & match approach with adenoviral vector-based vaccines as boosters
Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against Covid-19
Subscribe To Our Newsletter & Stay Updated
